Laura Pardo

1.5k total citations
45 papers, 711 citations indexed

About

Laura Pardo is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Laura Pardo has authored 45 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 16 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Laura Pardo's work include Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (9 papers) and CAR-T cell therapy research (8 papers). Laura Pardo is often cited by papers focused on Acute Myeloid Leukemia Research (24 papers), Acute Lymphoblastic Leukemia research (9 papers) and CAR-T cell therapy research (8 papers). Laura Pardo collaborates with scholars based in United States, Argentina and Spain. Laura Pardo's co-authors include Soheil Meshinchi, Michael R. Loken, Todd A. Alonzo, Robert B. Gerbing, Alan S. Gamis, Todd M. Cooper, Cristina Valero, Miquel Quer, Xavier León and Susana C. Raimondi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Laura Pardo

41 papers receiving 700 citations

Peers

Laura Pardo
Simonetta Kerim Italy
Michael Neat United Kingdom
Claudia Schöllkopf Denmark
Mohammad A. Vasef United States
Rocı́o Hassan Brazil
Lisa Lassay Germany
Jennifer A. Kanakry United States
Marc André Belgium
Agnès Boyer-Chammard France
Carol Boss United States
Simonetta Kerim Italy
Laura Pardo
Citations per year, relative to Laura Pardo Laura Pardo (= 1×) peers Simonetta Kerim

Countries citing papers authored by Laura Pardo

Since Specialization
Citations

This map shows the geographic impact of Laura Pardo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Pardo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Pardo more than expected).

Fields of papers citing papers by Laura Pardo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Pardo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Pardo. The network helps show where Laura Pardo may publish in the future.

Co-authorship network of co-authors of Laura Pardo

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Pardo. A scholar is included among the top collaborators of Laura Pardo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Pardo. Laura Pardo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ries, Rhonda E., et al.. (2023). Preclinical evaluation of targeting PRAME with TCR mimic CAR T cells in AML.. Journal of Clinical Oncology. 41(16_suppl). 2553–2553. 1 indexed citations
2.
Hudson, Chad A., Laura Pardo, Timothy P. Singleton, et al.. (2023). The impact of Down syndrome‐specific non‐malignant hematopoietic regeneration in the bone marrow on the detection of leukemic measurable residual disease. Cytometry Part B Clinical Cytometry. 104(4). 311–318. 4 indexed citations
3.
Leonti, Amanda R., Laura Pardo, Cristina L. Abrahams, et al.. (2023). Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia. Blood Advances. 7(9). 1666–1670. 7 indexed citations
4.
Lambo, Sander, Diane L. Trinh, Rhonda E. Ries, et al.. (2023). A longitudinal single-cell atlas of treatment response in pediatric AML. Cancer Cell. 41(12). 2117–2135.e12. 31 indexed citations
5.
Bashir, Saima, Mikel Terceño, María Buxó, et al.. (2022). Progressive Lacunar Strokes: A Predictive Score. Journal of Stroke and Cerebrovascular Diseases. 31(8). 106510–106510.
6.
Pardo, Laura, Amanda R. Leonti, Michael R. Loken, et al.. (2022). Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia. Blood Advances. 7(7). 1178–1189. 23 indexed citations
7.
Srivastava, Shivani, Jenny L. Smith, Amanda R. Leonti, et al.. (2021). Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia. Clinical Cancer Research. 27(20). 5718–5730. 17 indexed citations
8.
Lamble, Adam J., Lisa Eidenschink Brodersen, Todd A. Alonzo, et al.. (2021). CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group. Journal of Clinical Oncology. 40(3). 252–261. 26 indexed citations
9.
Venegas, María del Prado, Cristina Valero, Laura Pardo, et al.. (2021). The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients. Head & Neck. 43(7). 2091–2100. 6 indexed citations
10.
Bolouri, Hamid, Rhonda E. Ries, Laura Pardo, et al.. (2021). A B-cell developmental gene regulatory network is activated in infant AML. PLoS ONE. 16(11). e0259197–e0259197. 7 indexed citations
11.
Pardo, Laura, et al.. (2021). Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor Natural Killer Cell Therapy in Acute Myeloid Leukemia. Blood. 138(Supplement 1). 1712–1712. 3 indexed citations
12.
Smith, Jenny L., Benjamin J. Huang, Rhonda E. Ries, et al.. (2021). Targeting FOLR1 in High-Risk CBF2AT3-GLIS2 AML with Stro-002 FOLR1-Directed Antibody-Drug Conjugate. Blood. 138(Supplement 1). 209–209. 1 indexed citations
13.
Tarlock, Katherine, Todd A. Alonzo, Yi-Cheng Wang, et al.. (2019). Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia. Clinical Cancer Research. 25(16). 5038–5048. 39 indexed citations
14.
Valero, Cristina, Laura Pardo, Jacinto Garcı́a, et al.. (2019). Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma. Head & Neck. 42(2). 336–343. 54 indexed citations
15.
Kaeding, Allison, Katherine Tarlock, Sonali P. Barwe, et al.. (2017). Mesothelin Is a Novel Disease Marker and Potential Therapeutic Target in Pediatric Acute Myeloid Leukemia. Blood. 130. 2641–2641. 1 indexed citations
16.
Pardo, Laura, Cristina Valero, Montserrat López, et al.. (2016). The prognostic value of pretreatment platelet count in patients with head and neck squamous cell carcinoma. Auris Nasus Larynx. 44(3). 313–318. 15 indexed citations
17.
18.
Pardo, Laura & Nuria Lorenzo-Dus. (2010). The Falklands/Malvinas 25 years on: a comparative analysis of constructions of heroism on Argentinean and British television. Journal of Multicultural Discourses. 5(3). 253–270. 12 indexed citations
19.
20.
Pardo, Laura, et al.. (2005). Impact of FLT3 Mutational Status as Prognostic Factor in Acute Myeloid Leukemia Patients from Argentina and Uruguay.. Blood. 106(11). 4494–4494. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simonetta Kerim Breakdown of academic impact, for papers by Michael Neat Breakdown of academic impact, for papers by Claudia Schöllkopf Breakdown of academic impact, for papers by Mohammad A. Vasef Breakdown of academic impact, for papers by Rocı́o Hassan Breakdown of academic impact, for papers by Lisa Lassay Breakdown of academic impact, for papers by Jennifer A. Kanakry Breakdown of academic impact, for papers by Marc André Breakdown of academic impact, for papers by Agnès Boyer-Chammard Breakdown of academic impact, for papers by Carol Boss
Rankless by CCL
2026